First Citizens Bank & Trust CO Halozyme Therapeutics, Inc. Transaction History
First Citizens Bank & Trust CO
- $6.42 Billion
- Q4 2024
A detailed history of First Citizens Bank & Trust CO transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, First Citizens Bank & Trust CO holds 4,704 shares of HALO stock, worth $265,399. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,704
Previous 4,023
16.93%
Holding current value
$265,399
Previous $230,000
2.61%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HALO
# of Institutions
538Shares Held
124MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$994 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$728 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$374 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$229 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$192 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.86B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...